GlaxoSmithKline plc, announces board changes
17y agoen
From the article
GSK announces, Mr. James Murdoch has been appointed as a Non-Executive Director and will join the Board of the Company from 20/05/09.
Continue reading on GSKYou might also wanna read
Welcoming Sanjay Poonen to the Snyk Board of Directors
Snyk·4y ago
Roundtable–RYVYL Merger Advances with Board Appointment of Veteran Tech Banker Steven Fletcher
rtb.io·3mo ago
GSK acquires cancer drug developer Nuvalent in $10.6 billion deal
GSK has announced a $10.6 billion acquisition of Nuvalent, a biotech company developing small-molecule kinase inhibitors for treatment-resis
cen.acs.org·28d ago
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
ft.trib.al·1mo agoTechCreate Group Ltd. Announces Board of Director and Committee Composition Changes
stocktitan.net·1mo ago
GSK in talks to acquire Nuvalent for over $9 billion in largest deal in more than a decade
GSK is in talks to acquire biotech firm Nuvalent for more than $9 billion, which would be its largest acquisition in over a decade and the s
cnbc.com·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.